Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill

Rhea-AI Filing Summary

Orchestra BioMed Holdings director David Pacitti reported a single transaction involving company stock. On 2026-08-12, 3,761 shares of common stock were withheld at $4.42 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units. According to the company’s disclosure, no shares were sold in the market in connection with this event. After this withholding, Pacitti’s directly held stake totaled 54,750 shares of common stock.

Insider Trade Summary

Net Seller: 3,761 shares

Net Sell 1 txn

Insider Pacitti David

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.0001 per share F1	3,761	$4.42	$17K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 54,750 shares (Direct)

Footnotes (1)

1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Key Figures

Shares withheld for tax: 3,761 shares Withholding reference price: $4.42 per share Shares owned after transaction: 54,750 shares

3 metrics

Shares withheld for tax 3,761 shares Shares withheld on 2026-08-12 to satisfy tax withholding obligations on RSU vesting

Withholding reference price $4.42 per share Per-share value used for the 3,761-share tax-withholding transaction

Shares owned after transaction 54,750 shares Director David Pacitti’s direct OBIO common stock holdings after withholding

Key Terms

restricted stock units, tax withholding obligations, transaction code F

3 terms

restricted stock units financial

"in connection with vesting of restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with vesting of RSUs."

transaction code F financial

"transaction_code "F" indicates payment of tax liability by delivering securities."

FAQ

What insider transaction did Orchestra BioMed (OBIO) director David Pacitti report?

David Pacitti reported a tax-related withholding of 3,761 OBIO shares on 2026-08-12 tied to the vesting of restricted stock units. This was not an open-market sale, but shares withheld to cover tax obligations.

Were any Orchestra BioMed (OBIO) shares sold on the market in this Form 4?

No. The filing states that no shares were sold in the market. The 3,761 shares were withheld by the issuer solely to satisfy tax withholding obligations upon RSU vesting.

How many OBIO shares were withheld and at what price in Pacitti’s Form 4?

The transaction shows 3,761 shares of Orchestra BioMed common stock withheld at $4.42 per share. This reflects shares delivered or withheld to cover tax liabilities associated with vested restricted stock units.

How many Orchestra BioMed (OBIO) shares does David Pacitti hold after this transaction?

Following the tax-withholding transaction, David Pacitti directly holds 54,750 OBIO common shares. This figure reflects his post-transaction ownership as reported in the Form 4 filing.

Was the Orchestra BioMed (OBIO) Form 4 transaction under a Rule 10b5-1 plan?

The filing’s 10b5-1 indicator is unchecked, and the footnote does not reference any trading plan. The event is described as shares withheld for tax obligations upon RSU vesting, not as a pre-planned trading program.

What does transaction code F mean in the OBIO Form 4 for David Pacitti?

Transaction code F indicates payment of a tax liability or exercise price by delivering or withholding securities. Here, a footnote specifies it was for tax withholding obligations related to vested restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:25 PM Accepted by SEC EDGAR 08/14/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pacitti David

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	08/12/2026		F(1)		3,761	D	$4.42	54,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)